Business & Finance
Strong sales of bone and RA drugs drive Amgen's Q2 profit
Bloomberg Businessweek Jul. 27, 2012
Novartis resumes production of migraine drug Excedrin
The Wall Street Journal Jul. 26, 2012
Biocon anticipates launching psoriasis drug by end of fiscal 2013
Reuters Jul. 26, 2012
Government & Legal News
Horizon's anti-inflammatory drug Rayos gains FDA approval
Reuters Jul. 26, 2012
EU approves Boehringer and Lilly's Jentadueto for type 2 diabetes
Diabetes.co.uk (U.K.) Jul. 26, 2012
FDA speeds review of GSK and Ligand's Promacta for thrombocytopenia
Pharmaceutical Business Review Online Jul. 26, 2012
FDA will expedite review of hepatitis C drug by Idenix
Pharmaceutical Business Review Online Jul. 26, 2012
FDA allows Phase I trial of cancer vaccine by ImmunoCellular
Pharmaceutical Business Review Online Jul. 26, 2012
Pipeline/R&D News
Karyopharm begins 2 Phase I studies of tumor suppressant
Mass High Tech (Boston) Jul. 26, 2012
Tradjenta shows long-term benefit in type 2 diabetes trial
Medscape (free registration) Jul. 26, 2012, Endocrine Today Jul. 25, 2012
Gilead's cobicistat fares well in HIV study
MedPage Today Jul. 26, 2012
Study: Pfizer's Rapamune cuts skin cancer risk in kidney patients
MedPage Today Jul. 26, 2012
